COMMUNIQUÉS West-GlobeNewswire

Rendever and Lenovo Collaborate to Bring Virtual Reality Experiences to Carolina Caring Seniors

19/06/2024 - 15:00

The joint project fuses Rendever’s platform with Lenovo’s ThinkReality VRX headset for an all-in-one VR approach that enhances the quality of life of older adults BOSTON, June 19, 2024 (GLOBE NEWSWIRE) -- Rendever , the [...]

Sharecare announces inducement grants under Nasdaq Listing Rule 5635(c)(4)

19/06/2024 - 14:30

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR ), the digital health company that helps people manage all their health in one place, today announced that on June 14, 2024, its Board of Directors (the [...]

Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association

19/06/2024 - 14:00

Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people with diabetic peripheral neuropathic pain (DPNP) Investigators conclude that [...]

Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry

19/06/2024 - 14:00

LOS ANGELES, June 19, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of DCS Innovative Diagnostik-Systeme GmbH & Co. KG (“DCS” or the “Company”), a German supplier of reagents and [...]

Calibre Scientific fait l’acquisition de DCS, un fournisseur allemand spécialisé dans les anticorps, les réactifs et les équipements utilisés en immunohistochimie

19/06/2024 - 14:00

LOS ANGELES, 19 juin 2024 (GLOBE NEWSWIRE) -- Calibre Scientific a le plaisir d’annoncer l’acquisition de DCS Innovative Diagnostik-Systeme GmbH & Co. KG (« DCS » ou la « Société »), un fournisseur allemand [...]

Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors

19/06/2024 - 14:00

REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]

Avicanna Announces USPTO Issuance of Patent SEDDS Technology

19/06/2024 - 13:30

Patent No. US 11,998,632 B2 (“Patent”) covers Avicanna’s self-emulsifying drug delivery system (“SEDDS”) oral cannabinoid composition and methods of treating neuropathic pain TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- [...]

Philips completes cancellation of 4.4 million shares

19/06/2024 - 13:00

June 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the [...]

Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development

19/06/2024 - 10:00

Laboratory of Prof. Andrea Alimonti at IOR (Institute of Oncology Research, Bellinzona, Switzerland) and Macomics to bring together expertise on myeloid-derived suppressor cells in prostate cancer mouse model systems [...]

Nicox annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription sous forme d’ABSA d’un montant total de 3,3 millions d’euros et étend son horizon de trésorerie

19/06/2024 - 07:30

Communiqué de presse Nicox annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription sous forme d’ABSA d’un montant total de 3,3 millions d’euros et étend son horizon de [...]

Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens

19/06/2024 - 02:57

Fully underwritten Retail Entitlement Offer to open at 9:00 am (Melbourne time) on 19 June 2024 Retail Entitlement Offer to raise approximately A$55.0m (US$36.9m 1 ) will close at 5:00 pm (Melbourne time) on 10 July [...]

Cannabix Technologies Annual General and Special Meeting Results

19/06/2024 - 01:00

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common [...]

Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma

19/06/2024 - 00:22

Webcasted conference call on Thursday, June 20, 2024 at 8:30 a.m. ET BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first [...]

Aptose Announces Results from Annual and Special Meeting of Shareholders

18/06/2024 - 23:30

SAN DIEGO and TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]

Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction

18/06/2024 - 22:48

MIAMI, June 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for rare, life- [...]

Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit

18/06/2024 - 22:30

SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]

EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner

18/06/2024 - 22:30

Celebrating the bold leaders who disrupt markets, revolutionize industries and transform lives SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) today announced that Scott Struthers, Ph.D., [...]

Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy

18/06/2024 - 22:05

- RMAT designation follows positive data update from the ongoing Phase 1/2 clinical trial of NRTX-1001 cell therapy, demonstrating a favorable safety profile to date and the potential to significantly reduce seizure [...]

Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology

18/06/2024 - 22:05

SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage, self-sustainable biotechnology company developing anti-fibrotic therapeutics for a variety of chronic organ [...]